Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Leslie Zacks currently holds 71,675 shares of SCIELE PHARMA, INC. (SCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leslie Zacks has been a net seller of SCRX stock. They have purchased $0 and sold $632.7K worth of shares.
Leslie Zacks's most recent insider trade was on May 19, 2008, when they sold 1,625 shares at $21.71 per share.
Leslie Zacks serves as Executive at SCIELE PHARMA, INC. (SCRX). They have executed 13 insider transactions totaling $632.7K over their tenure at the company.
Leslie Zacks holds the position of Executive at SCIELE PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Leslie Zacks has shown a selling trading pattern, with $0 in total purchases and $632.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Leslie Zacks was on Dec 5, 2007, when they purchased $704.0K worth of SCRX shares. This transaction involved 32,000 shares at $22.00 per share.
Leslie Zacks currently owns 71,675 shares of SCIELE PHARMA, INC. (SCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Leslie Zacks's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Leslie Zacks has 13 Form 4 filings on record as an insider at SCIELE PHARMA, INC..
Set alerts for Leslie Zacks and 40,000+ other insiders.